drugset / Trial / NCT07459452
Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This Phase II Trial is Meant to Evaluate the Efficacy, and Safety of JYB1904 Injection in Patients With Perennial Allergic Rhinitis.
Timeline
- Start
- 2026-04
- Primary completion
- 2027-10
- Completion
- 2028-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | OZUREPRUBART | Monoclonal antibody | 300 mg | Subcutaneous |